Ligand-targeted nanocarriers are desirable for their potential to enhance precise drug delivery to targeted tissues, but their clinical translation faces challenges like protein corona formation. Here, Li et al. develop surface-galloylated liposomes that enable stable, non-covalent adsorption of antibodies while overcoming protein corona interference.
- Jinbo Li
- Jiang Yu
- Yongjun Wang
